First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast's Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome

Press/Media

Period6 May 2020

Media coverage

1

Media coverage

  • TitleFirst Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast's Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date6/05/20
    PersonsAlan Moskowitz, Emilia Bagiella, Annetine Gelijns
View all 1
View less